Search Results
Jan 20, 2026, 09:00 ET Coinbase Launches NBA Rookie Firsts Content Series Spotlighting the Next Generation of NBA Stars and the Future of Money
Niederhauser and the personal and professional moments that define their rookie year.For more information, visit coinbase.com.Hi-res assets can be downloaded
More news about: Coinbase
Jan 20, 2026, 08:49 ET Kyiv-Based Horizon Capital Backs Notus Energy in Launching a 124 MW Wind Power Project in Ukraine as the First Investment from Horizon Capital Catalyst Fund, its Newest Fund
capacity, create high-skilled technical jobs, and contribute to Ukraine's sustainability goals. We view Ukraine as a market with strong fundamentals for RES deployment, and this transaction lays the ground for Notus Energy to propel our mid-term development pipeline in Ukraine, with an ambition to reach 1.3
More news about: Horizon Capital
Jan 20, 2026, 08:40 ET Kyiv-Based Horizon Capital Backs Notus Energy in Launching a 124 MW Wind Power Project in Ukraine as the First Investment from Horizon Capital Catalyst Fund, its Newest Fund
capacity, create high-skilled technical jobs, and contribute to Ukraine's sustainability goals. We view Ukraine as a market with strong fundamentals for RES deployment, and this transaction lays the ground for Notus Energy to propel our mid-term development pipeline in Ukraine, with an ambition to reach 1.3
More news about: Horizon Capital
Jan 20, 2026, 08:25 ET Volition Continues to Extend Access to Nu.Q® Vet Cancer Test
Bygott, T., Kelly, T.K. et al. Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs. BMC Vet Res 18, 329 (2022). https://doi.org/10.1186/s12917-022-03429-8Data
More news about: VolitionRx Limited
Jan 20, 2026, 07:45 ET Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer
epithelial ovarian cancer." Gynecologic oncology vol. 108,3 (2008): 619-26. doi:10.1016/j.ygyno.2007.11.020. 4 Viricel W, et al. Cancer Res. 2023;83(suppl 7):1544.
More news about: Eli Lilly and Company
Jan 20, 2026, 07:00 ET RPC, Inc. Announces Date for Fourth Quarter 2025 Financial Results and Conference Call
ATLANTA, Jan. 20, 2026 /PRNewswire/ -- RPC, Inc. (NYSE: RES) announced today that it will release its financial results for the fourth quarter and year ended December 31, 2025 on Tuesday, February 3, 2026 before
More news about: RPC, Inc.
Jan 19, 2026, 10:03 ET RefrigiWear® Announces Improvements to Best-Selling ComfortGuard™ Cold-Weather Workwear
pro.refrigiwear.com or call 800-654-3744.To view and download hi-res images, please visit
More news about: RefrigiWear, LLC
Jan 18, 2026, 20:00 ET 德昇濟醫藥獲美國 FDA 批准兩項 IND 申請，推進 D3S-003 開展 I 期臨床試驗，並啟動 Elisrasib（D3S-001）與 D3S-002 的 II 期聯合用藥臨床試驗
為選擇性 ERK1/2 抑制劑，面向聯合治療策略進行優化設計，通過對 MAPK 通路實施「縱向抑制」以增強療效並克服獲得性耐藥，尤其適用於既往接受過 KRAS G12C 抑制劑治療的腫瘤。主要發表文獻：Cancer Res 1 April 2023; 83 (7_Supplement): 5501. 關於 D3S-003D3S-003
More news about: 德昇濟醫藥（D3 Bio）
Jan 18, 2026, 20:00 ET D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
overcome acquired resistance, particularly in tumors previously treated with KRAS G12C inhibitors.Key publication:Cancer Res 1 April 2023; 83 (7_Supplement): 5501. About D3S‑003D3S‑003 is a differentiated KRAS G12D
More news about: D3 Bio
Jan 16, 2026, 11:04 ET RefrigiWear® Supports Western Alaska Flood Recovery with Critical Cold-Weather Gear Donation Through 6th Avenue Outfitters
conditions anywhere. Our role is to support the people putting in the effort to get their communities back on their feet."To view and download hi-res images, please visit
More news about: RefrigiWear, LLC
Jan 16, 2026, 08:45 ET Volition Sponsors Symposium at Veterinary Meeting and Expo
Bygott, T., Kelly, T.K. et al. Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs. BMC Vet Res 18, 329 (2022). https://doi.org/10.1186/s12917-022-03429-8
More news about: VolitionRx Limited
Jan 14, 2026, 15:07 ET DELIA OSEGUEDA JOINS AIC HOTEL GROUP AS VICE PRESIDENT OF GLOBAL PARTNERSHIPS
Hi-Res Image Here
More news about: AIC Hotel Group
Jan 14, 2026, 04:30 ET REGISTRATION FOR THE LA28 TICKET DRAW OPENS TODAY FOR TICKETS TO ALL OLYMPIC SPORTS
Athlete and Fan Journey to LA28at LA Memorial ColiseumASSETS: Links to hi-res photos and video follow.VIDEO: Hi-res video b-roll footage of LA28 Celebration on Eve of Ticket Registration OpeningLink:
More news about: LA28
Jan 13, 2026, 21:14 ET JAPAN SUI COLLECTION en Kioto: Llevando la esencia de la belleza y la tradición japonesas al mundo
tradicional "kyogen" destacaron las artes escénicas de Japón. La recepción incluyó platos elaborados con ingredientes de primera calidad, como carne de res "wagyu" de Yamagata y atún Oma, preparados por el chef Hiroshi Nagashima, maridados con sake de arroz seleccionado.Imágenes de espectáculos y
More news about: Cabinet Office, Government of Japan
Jan 13, 2026, 10:00 ET GovCIO Drives Early Impact in VA's RES Modernization Effort
GovCIO is proud to mark the successful early deployment of Phase 1 of the Readiness and Employment System (RES), a major milestone in the Department of Veterans Affairs (VA) ongoing modernization of the Veteran Readiness and Employment (VR&E) program.
More news about: GovCIO
Jan 13, 2026, 08:06 ET Let the Easter Fun Begin! PEEPS® Unveils Its 2026 Lineup
Facebook!To download high-res product images and product fact sheets click
More news about: Just Born Quality Confections
Jan 13, 2026, 08:00 ET Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting
Psychiatry. 2022;83(6):21r14328.Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2003;37(1):9-15. doi:10.1016/S0022-3956(02)00052-3Taddei-Allen P. Economic Burden and Managed Care Considerations for the Treatment of
More news about: Johnson & Johnson
Jan 13, 2026, 07:37 ET Tulavi Therapeutics Receives Innovative Technology Contract from Vizient for the allay™ Hydrogel Cap
Common Are Chronic Residual Limb Pain, Phantom Pain, and Back Pain More Than 20 Years After Lower Limb Amputation for Malignant Tumors? Clin Orthop Relat Res. 2021 Sep 1;479(9):2036-2044. doi: 10.1097/CORR.0000000000001725. PMID: 33739309; PMCID: PMC8373555.Dellon, A. L. (2001). Treatment of symptomatic
More news about: Tulavi Therapeutics, Inc.
Jan 13, 2026, 07:00 ET Bonkers Toys Pounce on Massive Success of Warrior Cats With Launch of New Toy Line at Retail
its treasured characters with their toy line, and we can't wait to see it become the next big chapter in the franchise."For hi-res images of Warrior Cats Series 1, please visit
More news about: Bonkers Toys
Jan 12, 2026, 11:00 ET Axon Vision Receives Order from Leonardo DRS for AI-Driven C-UAS systems
for deployment in diverse scenarios."We are proud to deepen our collaboration with Leonardo DRS through this new order," said Brig. Gen. (res.) Roy Riftin, CEO of Axon Vision. "Axon Vision's new C-UAS systems represent the next stage in delivering modular, AI-enabled solutions tailored
More news about: Axon Vision
Jan 12, 2026, 10:00 ET Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection
and machine learning to tune into cancer's subtlest clues, even at the earliest stages of the disease.References1. Clin Cancer Res (2025) 31 (13_Supplement): A045. doi/10.1158/aimachine-A045
More news about: Freenome Holdings, Inc.
Jan 12, 2026, 08:05 ET Rigel Provides Business Update and 2026 Outlook
https://www.cancer.org/cancer/types/lung-cancer/about/key-statistics.htmlKato, S. et al. RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients. Clin Cancer Res. 2017;23(8):1988-1997 doi: 10.1158/1078-0432.CCR-16-1679The American Cancer Society. Key Statistics for Acute Myeloid Leukemia (AML). Revised
More news about: Rigel Pharmaceuticals, Inc.
Jan 10, 2026, 10:00 ET RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
second-line cetuximab plus folinic acid/5-fluorouracil/irinotecan (FOLFIRI) in KRAS wild-type metastatic colorectal cancer: the FLIER study. Anticancer Res. 2014;34(4):1967-1973.8 Peeters M, Price TJ, Cervantes A, et al. Final results from a randomized phase 3 study of FOLFIRI {+/-}
More news about: Johnson & Johnson
Jan 09, 2026, 21:58 ET CES 2026: The Future is Here
high-res image gallery and
More news about: Consumer Technology Association
Jan 09, 2026, 20:31 ET CES 2026: The Future is Here
high-res image gallery and
More news about: Consumer Technology Association